Expert Review of Neurotherapeutics

SJR Rank #4,138H-index: 110SJR: 1.106Best quartile: Q1
Journal website: aims, scope and author guidelines
Publisher

Taylor and Francis Ltd.

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.30.60.91.2

Subject Categories

  • Neurology (clinical)Q1
  • Pharmacology (medical)Q1
  • Neuroscience (miscellaneous)Q2

Areas: Medicine · Neuroscience

Most published research topics

Neurological disorders and treatmentsEpilepsy research and treatmentParkinson's Disease Mechanisms and TreatmentsMultiple Sclerosis Research StudiesMigraine and Headache StudiesBipolar Disorder and TreatmentPharmacological Effects and Toxicity StudiesSchizophrenia research and treatmentAlzheimer's disease research and treatmentsGlioma Diagnosis and Treatment

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs075150225300

Documents per Year

202220250306090120

Detailed Information

ISSN

1473-7175, 1744-8360

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

4.13

References per Document

102.42

Coverage

2001-2026

Scope

Expert Review of Neurotherapeutics (ISSN 1473-7175) provides expert reviews on the use of drugs and medicines in clinical neurology and neuropsychiatry. Coverage includes disease management, new medicines and drugs in neurology, therapeutic indications, diagnostics, medical treatment guidelines and neurological diseases such as stroke, epilepsy, Alzheimer's and Parkinson's. Comprehensive coverage in each review is complemented by the unique Expert Review format and includes the following sections: Expert Opinion - a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results Article Highlights – an executive summary of the author’s most critical points

Metrics from SCImago Journal Rank 2025. View on SCImago